Sunshine Pharma (06887): Equity Transfer Among Controlling Shareholder Group Members

Stock News
2025/12/29

The Board of Directors of the Company has been informed by Mr. Zhang Yushuai and Ms. Guo Meilan, each a member of the Company's controlling shareholder group, that, in light of Ms. Guo's decision to retire and reduce her involvement in the Group's business, on December 29, 2025, Mr. Zhang and Ms. Guo entered into an equity transfer agreement.

Pursuant to the agreement, Ms. Guo transferred her 71.75% equity interest in Ruyuan Yao Autonomous County Yuneng Electronic Industrial Co., Ltd. and her 74.63% equity interest in Ruyuan Yao Autonomous County Xinjing Technology Development Co., Ltd. to Mr. Zhang.

The nominal consideration for each transfer was RMB 1.00. Ms. Guo is the mother of Mr. Zhang.

Following the completion of the relevant regulatory filings and the settlement of the equity transfers, Mr. Zhang will hold 99.2% and 75.0% equity interests in Ruyuan Yuneng Electronic and Ruyuan Xinjing Technology, respectively.

Consequently, Mr. Zhang will become the new leader of the controlling shareholder group, while Ms. Guo will cease to be a member of the group.

The Board of Directors is of the opinion that the equity transfer will not have any adverse impact on the overall financial and operational conditions of the Company.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10